The decreased atherosclerotic plaque formation observed in eNOS S1176D mice reinforces eNOS S1176 phosphorylation as a therapeutic target for ameliorating vascular pathologies associated with endothelial dysfunction. This evidence concerns the gene NOS3 and endothelial dysfunction.